AOD-9604

≥98% HPLCCOA per batchCold-chain shippedIn-house synthesisResearch use only · not for human consumption

Price range: $40.99 through $68.99

Independently verified Tested by IRZC Laboratories Batch NHV26-R5120 · Purity 98.47 % HPLC · Issued 4 Aug 2026 · Cert COA-SVD2-YMQV-9Verify at IRZCVerifyScan to verify

A modified fragment of human growth hormone (residues 176-191) developed specifically for fat loss without GH’s other hormonal effects.

FormulaC78H123N23O23S2
Mol. weight1815.08 g/mol
FormLyophilised powder
2 People watching this product now!
SKU: PEP-014 Category:

Molecular & analytical data

Verified chemistry and third-party reference identifiers for this compound.

Amino acid sequenceTyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Tyr-hGH(177-191); 16 amino acids, N-terminal Tyr in place of hGH Phe176; cyclic Cys7-Cys14 disulfide)
Molecular formulaC78H123N23O23S2
Molecular weight1815.08 g/mol
CAS number221231-10-3
PubChem CIDCID 71300630 ↗
Purity standard≥98%
Half-lifeNot established
BioavailabilitySubcutaneous: moderate; Oral: low
Origin / sourceSynthetic; fragment of human growth hormone
Year discovered1990s-2000s (Monash University, Australia)
AOD-9604 molecular structure
2D structure · source: PubChem

Reconstitution calculator

Concentration, volume per draw, and the graduation it measures to. Open the full bench calculator with this vial loaded →

Concentration— mg/mL— mcg per unit
—Draw tounits on a U-100 syringe
—Volume / drawmL
—Complete drawsper vial

—

A U-100 insulin syringe reads 100 units per 1 mL. Figures describe the contents of a vial for laboratory handling reference only and are not dosing guidance.

Quality & verification

Every batch is characterised before release and ships with documentation.

≥98%HPLC purity
1815.08 g/molMolecular weight
MS + HPLCIdentity & purity assay
Third-party testedBatches are tested by IRZC Laboratories — independent HPLC + mass-spec confirms identity and purity against that product’s release specification.
Batch-matched COAA certificate of analysis is issued per batch and matched to your vial’s lot number.
Cold-chain fulfilmentLyophilised product is packed with insulated, temperature-controlled shipping.
Controlled synthesisProduced under documented, reproducible in-house processes with lot traceability.

Storage & handling

Keep the peptide stable from delivery through reconstitution.

1
On arrivalStore the sealed, lyophilised vial frozen at −20°C, protected from light and moisture.
2
ReconstitutionAdd bacteriostatic water down the vial wall; swirl gently — do not shake. Use the calculator above to plan volume.
3
After mixingRefrigerate the reconstituted solution at 2–8°C and use within the stability window below.
4
HandlingWork in a clean area, wipe the stopper with alcohol, and avoid repeated freeze–thaw cycles.
Manufacturer storage note

Lyophilized at -20°C. Reconstituted at 2-8°C.

Description

AOD-9604 is a peptide fragment of human growth hormone (HGH) consisting of amino acids 176-191, with the addition of a tyrosine at the C-terminus. It was developed specifically to isolate the fat-burning properties of HGH without its growth-promoting or diabetogenic effects. AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat storage) without affecting blood sugar levels or promoting growth. Early research also suggested potential benefits for cartilage repair and joint health, leading to TGA (Australian) approval as an injectable for osteoarthritis in that market.

Certificates of Analysis

Certificates of Analysis

Every batch of this peptide is tested before release. Find the batch number printed on your vial and verify or download its certificate.

Batch #IssuedPurityCertificate
NHV26-R5120
COA-SVD2-YMQV-9
04 Aug 202698.47 % HPLCVerify at IRZC ↗

“Verify at IRZC” opens the laboratory’s own record for that certificate, on their site. Looking for an older batch we haven’t published? Email [email protected] with the batch number from your vial — we keep all certificates for 7 years.

Research & Literature
Reported in research literature — not usage guidance.

The information below summarises published preclinical and clinical research for scientific reference. NHOV products are sold strictly for laboratory research use only. Nothing here is medical advice, a recommendation, or an instruction for use in humans or animals.

Mechanism of action

Stimulates lipolysis by a mechanism not directly mediated through the beta-3 adrenergic receptor, although treatment increases beta-3 adrenergic receptor expression, inhibits lipogenesis, does not affect IGF-1 or insulin sensitivity, potential cartilage chondrocyte stimulation. Acts on fat cells without full GH receptor activation.

Primary uses / indications

Fat loss, weight management, body composition, cartilage repair research, joint health

Typical dosage (reported)

250-500 mcg daily, injected into abdominal fat (targeted). Often taken fasting in the morning.

Cycle duration (reported)

12-24 weeks for body composition research

Administration route

Subcutaneous injection, Oral (emerging research)

Side effects (reported)

Injection site reactions, headache, mild nausea. Generally well-tolerated in clinical studies. FDA cites immunogenicity concerns.

Contraindications

Active cancer, pregnancy/breastfeeding, known hypersensitivity

Drug interactions

No significant GH-axis interactions. Does not affect insulin or blood glucose.

Reviews (0)
0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “AOD-9604”

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.

Specifications

Identity

Full name / brand namesAOD-9604 (Advanced Obesity Drug-9604)
CategoryGrowth Hormone Secretagogues
SubcategoryHGH Fragment / Fat Loss
Origin / sourceSynthetic; fragment of human growth hormone
Year discovered1990s-2000s (Monash University, Australia)

Chemistry

Amino acid sequenceTyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (Tyr-hGH(177-191); 16 amino acids, N-terminal Tyr in place of hGH Phe176; cyclic Cys7-Cys14 disulfide)
Molecular formulaC78H123N23O23S2
Molecular weight1815.08 g/mol
CAS number221231-10-3
PubChem CIDCID 71300630 ↗
Purity standard≥98%

Pharmacokinetics

Half-lifeNot established
BioavailabilitySubcutaneous: moderate; Oral: low

Regulatory & research status

FDA statusNot FDA-approved. Proposed by FDA to not be included on bulk drug substances list. Prohibited for compounding due to safety concerns.
Prescription requiredResearch use only in US; available by prescription in some countries
Research statusPhase IIb clinical trials for obesity; development halted after poor efficacy. Not FDA-approved.
Clinical trialsPhase IIa/IIb (OPTIONS trial, obesity; terminated 2007 for lack of efficacy)

References

Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM, "The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta3-AR knock-out mice", Endocrinology, 2001;142(12):5182-5189, DOI: 10.1210/endo.142.12.8522; Stier H, Vos E, Kenley D, "Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans", Journal of Endocrinology and Metabolism, 2013;3(1-2):7-15

Frequently asked questions

What is AOD-9604?
A modified fragment of human growth hormone (residues 176-191) developed specifically for fat loss without GH's other hormonal effects.
How does AOD-9604 work?
Reported in the research literature: Stimulates lipolysis by a mechanism not directly mediated through the beta-3 adrenergic receptor, although treatment increases beta-3 adrenergic receptor expression, inhibits lipogenesis, does not affect IGF-1 or insulin sensitivity, potential cartilage chondrocyte stimulation. Acts on fat cells wit…
What AOD-9604 dosage is used in research?
For laboratory research reference only, not usage guidance: 250-500 mcg daily, injected into abdominal fat (targeted). Often taken fasting in the morning.
What is the half-life of AOD-9604?
The reported biological half-life of AOD-9604 is approximately Not established.
How should AOD-9604 be stored and reconstituted?
NHOV ships AOD-9604 as a lyophilised powder. Store unopened vials at −20 °C. Reconstitute with bacteriostatic water; once reconstituted, refrigerate at 2–8 °C, protect from light, and use within the bacteriostatic-water shelf window. Use the NHOV reconstitution calculator to find the exact volume for your target concentration.
What purity is NHOV's AOD-9604?
NHOV AOD-9604 is released against a specification of ≥98%, verified by HPLC with mass-spectrometry identity confirmation, and ships with a batch-specific Certificate of Analysis (COA) matched to the vial's lot number.
Is AOD-9604 approved for human use?
No. AOD-9604 is sold strictly for laboratory and scientific research use only. It is not for human or veterinary consumption and is not approved as a drug.